Epilepsy in MS and its association with cognitive and psychological burden [0.03%]
多发性硬化症中的癫痫与认知和心理负担的关系
Valeria Pozzilli,Carla Tortorella,Luca Prosperini et al.
Valeria Pozzilli et al.
Background: Epilepsy is two to three times more common in patients with multiple sclerosis (pwMS) compared to the general population. Patients with MS and epilepsy without other identifiable causes (MS + E) show greater c...
Enhanced cognitive outcomes with telehealth-based tDCS in multiple sclerosis: Results from a sham-controlled RCT [0.03%]
基于远程医疗的经颅直流电刺激治疗多发性硬化症的认知增强效应：一项假刺激对照随机试验的结果分析
Leigh Charvet,Judith Goldberg,Xiaochun Li et al.
Leigh Charvet et al.
Background: Cognitive impairment is common in multiple sclerosis (MS). Transcranial direct current stimulation (tDCS) combined with adaptive cognitive training (aCT) may improve clinical outcomes. ...
Music therapy with a monochord in multiple sclerosis ("MUTIMS"): A randomized, controlled, rater-blinded trial [0.03%]
单弦琴音乐疗法治疗多发性硬化症("MUTIMS")：一项随机对照试验
Jenni Kuhlmann,Katarina Ebner,Andrea Zimmer et al.
Jenni Kuhlmann et al.
Background: Mood-behavioral symptoms, fatigue and pain are frequent among people with multiple sclerosis (pwMS). Music therapy (MT) is a non-pharmacological option for symptomatic treatment in neurological diseases. ...
Delphi panel to understand the real-world occurrence and management of ofatumumab injection-related reactions among healthcare providers of people with relapsing multiple sclerosis [0.03%]
了解Ofatumumab注射相关反应的实际发生和管理的德尔菲专家调查：来自复发性多发性硬化症患者的医疗保健提供者的意见
Shiv Saidha,John Kramer,Brandon Brown et al.
Shiv Saidha et al.
Background: People with relapsing forms of multiple sclerosis (PwRMS) treated with ofatumumab, a fully human anti-CD20 monoclonal antibody, can experience local/systemic injection-related reactions (IRRs). However, data o...
Association of autoimmune comorbidities in persons with multiple sclerosis from a population-based study with genetic linkage [0.03%]
一项基于遗传连锁的以人群为基础的研究中多发性硬化症患者自身免疫共病的相关性
Roberto Gnavi,Nadia Barizzone,Roberta Picariello et al.
Roberto Gnavi et al.
Background: Comorbidities are a critical concern for clinicians in both the treatment and diagnosis of multiple sclerosis. Autoimmune diseases, including multiple sclerosis, often co-occur within individuals. However, mos...
Mahdi Barzegar,Sara Samadzadeh,Kosar Kohandel et al.
Mahdi Barzegar et al.
Background and objectives: Cardiovascular diseases (CVD) and their risk factors supposedly occur frequently in patients with multiple sclerosis (pwMS). We investigated prevalence of comorbidity particularly CVD among pwMS...
The effect of the EXOPULSE Mollii suit on motor functions in patients with multiple sclerosis - a randomized sham-controlled crossover trial [0.03%]
EXOPULS Mollii套装对多发性硬化患者运动功能的影响-一项随机假对照交叉试验
Samar S Ayache,Joseph G Mattar,Alain Créange et al.
Samar S Ayache et al.
Background: Patients with multiple sclerosis (PwMS) could suffer from frequent and disabling motor symptoms, including balance and mobility problems, spasticity, weakness and fatigue, with an impact on patients' quality o...
A review of the validation of the Brief Cognitive Assessment for Multiple Sclerosis in Latin America [0.03%]
拉美地区简明多发性硬化认知评估验证的综述
Miriam E Jiménez-Maldonado,Edgar R Valdivia-Tangarife,Miguel Ángel Macías-Islas et al.
Miriam E Jiménez-Maldonado et al.
Background: The present review aimed to identify published studies that reported the validation of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS) in Latin America (LATAM). ...
Blood-brain barrier permeability in relation to disease severity and timing of multiple sclerosis diagnosis in optic neuritis [0.03%]
视神经炎患者的血脑屏障通透性与疾病严重程度及多发性硬化症的诊断时间的关系
Moschoula Passali,Maria Højberg Knudsen,Knud Josefsen et al.
Moschoula Passali et al.
Background: Dynamic contrast-enhanced magnetic resonance imaging is a promising biomarker allowing for in vivo quantification of blood-brain barrier permeability. ...
Metabolic labeling kinetics of brain-derived 24S-hydroxycholesterol in blood in multiple sclerosis: Effects of treatment with the remyelinating antibody rHIgM22 [0.03%]
多发性硬化症中大脑衍生的24S-羟基胆固醇的代谢标记动力学在血液中的变化：接受促进再髓鞘化抗体rHIgM22治疗的影响
Mahalakshmi Shankaran,Kelvin W Li,Hussein A Mohammed et al.
Mahalakshmi Shankaran et al.
Background: Cholesterol is an essential and major component of myelin. Brain cholesterol turnover in humans can be studied noninvasively by metabolic labeling of the brain-specific cholesterol metabolite, 24S-hydroxychole...